News about

Piramal Pharma Solutions announces production first batches at new API facility in Michigan

The initial production run is the culmination of capital expenditure of $38 million in equipment and construction costs
<br />

| 20/02/2023 | By |  1195

US FDA gives tentative approval to Zydus Lifesciences for Bosentan tabs, oral suspension

The drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad

| 16/02/2023 | By |  539

Zydus Lifesciences bags tentative US FDA approval for diabetes drug Canagliflozin

The drug will be manufactured at the group's formulation manufacturing facility at Moraiya

| 16/02/2023 | By |  521

Aurobindo Pharma gets VAI classification from USFDA for Telangana facility

An API intermediate facility situated at Gundlamachnoor Village, Sangareddy District, Telangana, was inspected by the US FDA from November 10 to November 18, 2022

| 15/02/2023 | By |  966

Eli Lilly inks deal with Bangladesh's International Agencies to supply API for human insulin

The move is part of a bid to increase access and improve insulin affordability for nearly 1 million people with diabetes in Bangladesh by 2030

| 15/02/2023 | By |  1099

NATCO submits ANDA with US FDA for Olaparib tabs in US

Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostate cancer.

| 15/02/2023 | By |  1159

Solara Active Pharma Sciences' Cuddalore facility completes EU GMP Inspection

The inspection was carried out jointly by the State Institute for Drug Control (SUKL), Ministry of Health of the Czech Republic and National Authority of Medicines and Health Products (INFARMED), Portugal from February 7 to 9, 2023
<br />

| 15/02/2023 | By |  665

Sun Pharma recalls more than 34,000 bottles of generic medication in US

The lot was manufactured at the Mumbai-based drugmaker's Halol-based manufacturing facility in Gujarat that has failed dissolution testing

| 13/02/2023 | By |  898

Meenakshi Nevatia joins Pfizer as MD and Additional Director, effective April 3

Nevatia has nearly 30 years of business leadership and consulting experience with top companies

| 13/02/2023 | By |  965

Lupin bags US FDA approval for Glycopyrrolate injection

This is the first approval from Lupin’s injectable facility in Nagpur

| 13/02/2023 | By |  576